SOLID PSEUDOPAPILLARY NEOPLASM OF THE PANCREAS: PRESENTATION OF A CASE AND REVIEW OF THE LITERATURE

2021 ◽  
pp. 140-141
Author(s):  
Fabricio Andrés Lasso Andrade ◽  
Jorge Alejandro Cadena Arteaga ◽  
Denny Marcela Achicanoy Puchana ◽  
Thanya Mariselle Lagos ◽  
Hermes Albeiro Ortega Díaz ◽  
...  

Solid pseudopapillary neoplasms (SPN) of the pancreas are rare tumors, occurring in 1-2% of all pancreatic neoplasms; of these 10 to 15% have an aggressive presentation. Most of the patients present disease localized to the pancreas, however, between 9-15% may present local invasion and metastasis. The clinical presentation in the vast majority of SPN is asymptomatic, even despite a large tumor size. We present a case of a 16-year-old female patient with a psedupapillary tumor of the pancreas (Frantz tumor) who was admitted due to abdominal pain and weight loss lasting 3 months.

2021 ◽  
Vol 7 (1) ◽  
pp. 60-64
Author(s):  
Dr. Sabina Khan ◽  
◽  
Dr. Monal Trisal ◽  
Dr. Musharraf Husain ◽  
Dr. Shaan Khetrapal ◽  
...  

Solid Pseudopapillary Neoplasm of Pancreas (SPNP) is a rare, low-grade malignant solid-cysticneoplasm with papillary architecture. It accounts for 2% to 3% of pancreatic neoplasms and 0.9% to2.7% of exocrine pancreatic neoplasms. It occurs almost exclusively in young women and has anexcellent postsurgical curative rate. Metastasis is rare although it may be locally aggressive. Thesolid pseudopapillary neoplasm of the pancreas pose a diagnostic challenge both clinically andradiologically as it has a nonspecific clinical presentation with vague radiologic features.Histopathological evaluation and immunohistochemistry remains the gold standard in reaching adefinitive diagnosis. Due to its low incidence, the clinical and pathologic features of SPNP have notbeen extensively studied. We report a case of a 32-year-old lady with solid pseudopapillaryneoplasm of the pancreas that was suspected on abdominal CECT as a well-defined mass in theampullary-periampullary region abutting head of the pancreas and confirmed on histopathologicalevaluation with immunohistochemistry.


Author(s):  
SM Sharma

ABSTRACT Small intestinal tumors are rare despite small gut being a long structure with extensive mucosal surface. The clinical presentation is vague and the existence of tumor is detected after specific investigations. Small gut can be benign or may be malignant. Malignant tumors present with abdominal pain, weight loss, anemia, obstructive features, abdominal lump, diarrhea, intussusception and even fever depending upon the type of lesion. Malignancy occurs generally in elderly group above 60 years; however, younger patients too may be affected. Benign lesions may remain asymptomatic for long till these cause complications like intussusception or obstruction. Early detection and appropriate intervention can avoid morbidity and mortality. How to cite this article Sharma SM. Small Intestinal Tumors. Int J Adv Integ Med Sci 2016;1(1):9-12.


Neurosurgery ◽  
2003 ◽  
Vol 52 (4) ◽  
pp. 950-954 ◽  
Author(s):  
Doron Rabin ◽  
Lee Cyn Ang ◽  
Joseph Megyesi ◽  
Donald H. Lee ◽  
Neil Duggal

Abstract OBJECTIVE AND IMPORTANCE Desmoplastic fibroma is a benign bone tumor that can be locally aggressive. It usually occurs in the long bones and mandible. We report on a patient with a desmoplastic fibroma arising in the temporal bone and review previously published cases of desmoplastic fibroma originating within the cranium. CLINICAL PRESENTATION A 43-year-old woman presented with a 12-year history of progressively worsening head asymmetry. Magnetic resonance imaging and computed tomography demonstrated a mass originating from the bone and involving the adjacent soft tissues. INTERVENTION A temporal parietal craniectomy was performed with excision of a large tumor involving the bone. An acrylic cranioplasty was used to replace the bone. Pathological examination of the lesion identified desmoplastic fibroma of the cranium. After surgery, the patient's cranial asymmetry was corrected. CONCLUSION Desmoplastic fibroma of the cranium is rare. Surgical resection is the treatment of choice.


2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Weam El Hajj ◽  
Gilbert Nakad ◽  
Antoine Abou Rached

Strongyloidiasis is a helminthic disease which affects millions around the world resulting in a significant burden in certain high risk groups. It is rarely reported in the Lebanese population probably due to the low index of suspicion in common practice. We are reporting a case of strongyloidiasis that was found in an elderly patient presenting initially with dyspnea followed by skin rash, protein loosing enteropathy, diarrhea, and abdominal pain while on corticosteroid therapy. The diagnosis was suspected based on clinical presentation in addition to peripheral eosinophilia. We will also describe the upper and lower endoscopic aspects of the disease, as well as histologic findings on duodenal and colonic biopsies.


2020 ◽  
Vol 50 (2) ◽  
Author(s):  
Gabriel Lorente Mitsumoto ◽  
Lucas Augusto Monetta da Silva ◽  
Mauricio Alves Ribeiro ◽  
Mariana Martins Tocchio ◽  
Nátalie Emy Yvamoto ◽  
...  

Mirizzi syndrome (MS) is a rare condition whose clinical presentation is unspecific, with obstructive jaundice being the most common form. MS is often not recognized at initial presentation, which can result in morbidity and biliary injury. Preoperative diagnosis is uncommon and over 50% of patients with MS are diagnosed during surgery. There are no clinical features to distinguish MS from cholangiocarcinoma, except that patients with cholangiocarcinoma are on average ten years older than patients with MS. We report the case of a 51-year-old female patient who presented with jaundice and weight loss. Following investigation with laboratory and imaging exams, the initial diagnosis was Bismuth II cholangiocarcinoma. The patient underwent surgical intervention, and anatomopathological examination of the specimen showed the correct diagnosis to be MS. Despite the rarity of its incidence, physicians must keep MS in mind as a possible differential diagnosis for cholangiocarcinoma and vice-versa. We discuss this case in the context of a brief review of the literature on Mirizzi syndrome mimicking cholangiocarcinoma.


2021 ◽  
Vol 14 (1) ◽  
pp. 14-18
Author(s):  
Subash Bhattarai ◽  
Om Bahadur Karki ◽  
Merina Gyawali ◽  
Sudeep Regmi

Introduction: Colorectal cancer is the most common malignancy of the gastrointestinal tract. They are common after 50 years of age and present with bleeding per rectum, altered bowel habits, anemia, pain abdomen, and weight loss. The objective of this study was to evaluate the demographic profile, clinical presentation, colonoscopy and histopathology findings of colorectal cancer. Methods: A descriptive cross-sectional study was conducted. Cases were studied from the departmental records. Clinical presentation, CT abdomen, colonoscopy, and histopathology findings of colorectal carcinoma were studied. Data entry was done in SPSS version 20. Results: The mean age of subjects was 56 ± 11.42 years (range of 34 – 80 years) with male predominance (M: F=3:2). Changes in bowel habits (92.3%), chronic abdominal pain (84.6%), generalized weakness (80.7%), rectal bleeding (46.2%), and significant weight loss (42.3%) were the most common presenting symptoms. Rectal carcinoma was the most common (35%) followed by carcinomas of ascending colon (14%) and descending colon (10 %). The most common morphology was proliferative growth (61.5%). All colorectal carcinomas were adenocarcinoma, and the majority was moderately differentiated (51.9%). Conclusion: Colorectal cancers are seen above 50 years of age and common in males. Changes in bowel habits, chronic abdominal pain, generalized weakness, rectal bleeding, and weight loss are the most common form of presentations. These patients usually present late with advanced disease and unfavorable histopathology. Screening colonoscopy >50 years is strongly recommended.


2015 ◽  
Vol 2015 ◽  
pp. 1-4 ◽  
Author(s):  
İlkay Çamlıdağ ◽  
Mehmet Selim Nural ◽  
Murat Danacı ◽  
İlhan Karabıçak ◽  
Kağan Karabulut

Cystic dilatations of the cystic duct which are suggested as type VI biliary cysts are very rare and many of them go unrecognized or are confused with other cysts until the operation although they are obvious on imaging studies. They can present with fusiform or saccular dilatations and can be accompanied by common bile duct dilatations. It is important to identify these cysts as they share the same characteristics as the other biliary cyst types and can be complicated with malignancy. We herein present a very unusual case of a cholangiocarcinoma arising from a type VI biliary cyst in a 58-year-old female patient and review the literature. The patient presented with jaundice, weight loss, and abdominal pain. On imaging, the cystic duct and common bile duct were fusiformly dilated and had a wide communication. There was a mass filling the distal parts of both ducts. The patient was urgently operated on after perforation following ERCP. Histopathology was compatible with a type VI biliary cyst and an associated cholangiocarcinoma.


Author(s):  
Jeetendra P. Sah ◽  
Aaron W. Abrams ◽  
Geetha Chari ◽  
Craig Linden ◽  
Yaacov Anziska

AbstractIn this article, we reported a case of spinal muscular atrophy (SMA) type I noted to have tetraventricular hydrocephalus with Blake's pouch cyst at 8 months of age following intrathecal nusinersen therapy. The association of hydrocephalus with SMA is rarely reported in the literature. Development of hydrocephalus after intrathecal nusinersen therapy is also reported in some cases, but a cause–effect relationship is not yet established. The aim of this study was to describe the clinical characteristics of a patient with SMA type I and hydrocephalus, to review similar cases reported in the literature, and to explore the relationship between nusinersen therapy and development of hydrocephalus. The clinical presentation and radiographic findings of the patient are described and a comprehensive review of the literature was conducted. The adverse effect of communicating hydrocephalus related to nusinersen therapy is being reported and the authors suggest carefully monitoring for features of hydrocephalus developing during the course of nusinersen therapy.


Sign in / Sign up

Export Citation Format

Share Document